Keywords: Sanofi, Biogen Idec, Swedish Orphan Biovitrum, Novartis, Lemtrada, rFVIIFc, Agrippal, Flaud

News briefs from Sanofi, Biogen/SOBI and Novartis

Article | 01 November 2012

Print This

French drug major Sanofi (Euronext: SAN) and subsidiary Genzyme have reported results from pivotal studies - CARE-MS I and CARE-MS ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in